137 related articles for article (PubMed ID: 33134460)
1. Disseminated non-Langerhans cell histiocytosis with an IRF2BP2-NTRK1 gene fusion identified by next-generation sequencing.
Chan WH; Shah A; Bae G; Hambro C; Martin BA; Brown R; Novoa R; Kwong BY
JAAD Case Rep; 2020 Nov; 6(11):1156-1158. PubMed ID: 33134460
[No Abstract] [Full Text] [Related]
2. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis.
Hao X; Feng R; Bi Y; Liu Y; Li C; Lu T; Tian Y
J Neurosurg Pediatr; 2018 Sep; 23(1):48-53. PubMed ID: 30265230
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report.
Kim S; Lee M; Shin HJ; Lee J; Suh YL
Childs Nerv Syst; 2016 May; 32(5):893-6. PubMed ID: 26466952
[TBL] [Abstract][Full Text] [Related]
4. Diverse cutaneous manifestations of Erdheim-Chester disease in a woman with a history of Langerhans cell histiocytosis.
Neckman JP; Kim J; Mathur M; Myung P; Girardi M
JAAD Case Rep; 2016 Mar; 2(2):128-31. PubMed ID: 27051852
[No Abstract] [Full Text] [Related]
5. Langerhans cell histiocytosis and Erdheim-Chester disease.
Wilejto M; Abla O
Curr Opin Rheumatol; 2012 Jan; 24(1):90-6. PubMed ID: 22157416
[TBL] [Abstract][Full Text] [Related]
6. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
[TBL] [Abstract][Full Text] [Related]
7. Histopathological and Clinical Findings in Cutaneous Manifestation of Erdheim-Chester Disease and Langerhans Cell Histiocytosis Overlap Syndrome Associated With the BRAFV600E Mutation.
Liersch J; Carlson JA; Schaller J
Am J Dermatopathol; 2017 Jul; 39(7):493-503. PubMed ID: 27898473
[TBL] [Abstract][Full Text] [Related]
8. Effective treatment of progressive nodular histiocytosis by intermediate-dose cytarabine: a case report and literature review.
Wang JN; Qiu Y; Sun J; Niu N; Jiao Y; Zhu TN; Li J; Zhou DB; Cao XX
Am J Transl Res; 2021; 13(8):9040-9047. PubMed ID: 34540016
[TBL] [Abstract][Full Text] [Related]
9. Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease.
Váradi Z; Bánusz R; Csomor J; Kállay K; Varga E; Kertész G; Csóka M
Onco Targets Ther; 2017; 10():521-526. PubMed ID: 28182116
[TBL] [Abstract][Full Text] [Related]
10. Disseminated Langerhans cell histiocytosis in a 51-year-old man with cutaneous involvement and multiple endocrinopathies.
Voller LM; Totoraitis KE; Gaddis KJ; Pearson DR
JAAD Case Rep; 2019 Oct; 5(10):835-837. PubMed ID: 31646157
[No Abstract] [Full Text] [Related]
11. An unusual case of Erdheim-Chester disease with features of Langerhans cell histiocytosis.
Furmanczyk PS; Bruckner JD; Gillespy T; Rubin BP
Skeletal Radiol; 2007 Sep; 36(9):885-9. PubMed ID: 17492445
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation.
Johnson WT; Patel P; Hernandez A; Grandinetti LM; Huen AC; Marks S; Ho J; Monaco SE; Jaffe R; Picarsic J
J Cutan Pathol; 2016 Mar; 43(3):270-5. PubMed ID: 26454140
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological and molecular features of Erdheim-Chester disease accompanied with Langerhans cell histiocytosis].
Huang HJ; Zhong DR
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):220-224. PubMed ID: 30831649
[No Abstract] [Full Text] [Related]
15. Generalized eruptive histiocytosis associated with a novel fusion in LMNA-NTRK1.
Pinney SS; Jahan-Tigh RR; Chon S
Dermatol Online J; 2016 Aug; 22(8):. PubMed ID: 27617936
[TBL] [Abstract][Full Text] [Related]
16. CNS Erdheim-Chester Disease: A Challenge to Diagnose.
Pan Z; Kleinschmidt-DeMasters BK
J Neuropathol Exp Neurol; 2017 Dec; 76(12):986-996. PubMed ID: 29096034
[TBL] [Abstract][Full Text] [Related]
17. [Status of Langerhans cell histiocytosis in children and adults].
Kudo K
Rinsho Ketsueki; 2019; 60(9):1308-1316. PubMed ID: 31597857
[TBL] [Abstract][Full Text] [Related]
18. Erdheim-Chester disease: a comprehensive review.
Abdelfattah AM; Arnaout K; Tabbara IA
Anticancer Res; 2014 Jul; 34(7):3257-61. PubMed ID: 24982329
[TBL] [Abstract][Full Text] [Related]
19. [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review].
Adam Z; Balsíková K; Krejcí M; Pour L; Stĕpánková S; Svacina P; Hermanová M; Vanícek J; Krupa P; Stanícek J; Koukalová R; Neubauer J; Krivanová A; Mayer J; Hájek R
Vnitr Lek; 2010 Feb; 56(2):138-48. PubMed ID: 20329585
[TBL] [Abstract][Full Text] [Related]
20. Non-Langerhans cell histiocytosis with isolated CNS involvement: an unusual variant of Erdheim-Chester disease.
Conley A; Manjila S; Guan H; Guthikonda M; Kupsky WJ; Mittal S
Neuropathology; 2010 Dec; 30(6):634-47. PubMed ID: 20337948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
